Customer Info
COVID-19 ALERT
Continental is prepared to provide customers and physicians with materials needed. With FDA’s emergency IND approval, Continental is preparing to provide Convalescent Source Plasma from COVID-19 recovered patients.
Our products & services
- Whole Blood
- Serum
- Plasma in the desired anticoagulant
- Urine with matching blood test results
- Special Phenotype
- Profiles
- Rare antigens
- A/S or A/A
- HLA typed
- Source Leukocytes
- Negative for HBsAg, HIV 1-2, HCV and RPR
- Processed to customer specifications
- Delipidated for optical clarity
- pH adjusted as required
- 4% sodium citrate (or as specified)
- Activation inhibited (optional)
- Flash frozen at -70 deg. C. for maximum stability
- Negative for HBV, HIV 1-2, HCV and RPR
- Coumadin Plasma
- Normal Pool Plasma (custom aliquoting)
Individual donor plasmas can be drawn in Sodium Citrate, ACD, CPD, CPDA-1, Heparin or EDTA for specialized needs.
- Liquid or flash frozen at -70o C.
- Custom anticoagulants available
- Inhibitors (activation, fibrinolytic or general protease) can be added at time of draw or prior to freezing.
- Negative for HBsAg, HIV 1-2, HCV and RPR
Continental Services Group is licensed to perform automated plasmapheresis for in vitro applications. Donors can be selected and processed per customer requirements consistent with FDA guidelines. We also offer donor services to licensed entities that identify donors of interest.
Continental’s Source Plasma licensure allows draws from donors with the following disease-associated antibodies (IgG):
Wide choice of anticoagulants
- Negative for HBsAg, HIV 1-2, HCV and RPR
- Individual units or pools of up to 100 liters
- Male or female, as specified
- Blood group-specific (AB Negative, etc.)
- Custom specifications on request
Empty section. Edit page to add content here.
Contact sales for more information
We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.